<DOC>
	<DOCNO>NCT00542035</DOCNO>
	<brief_summary>This Phase 2 study design test ability investigational study drug ARRY-371797 reduce pain either perioperatively postoperatively third molar extraction pain model , evaluate drug 's safety . Approximately 150 subject US enrol study .</brief_summary>
	<brief_title>A Study ARRY-371797 Subjects Undergoing Third Molar Extraction</brief_title>
	<detailed_description />
	<mesh_term>Toothache</mesh_term>
	<criteria>Key Scheduled outpatient oral surgical procedure remove 2 ipsilateral third molar , least 1 mandibular fully partially impacted bone . Females childbearing potential must willing use acceptable method contraception within 14 day prior first dose study drug completion followup procedure . Body weight &gt; 50 kg ( 110 lb ) . Good health determine medical history , physical examination , vital sign clinical laboratory result nonclinical significance . Additional criterion exist . Key Positive urine drug screen . Use prescription nonprescription drug , herbal dietary supplement , vitamin , grapefruit juice within 14 day prior first dose study drug . Additional criterion exist .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Analgesia</keyword>
</DOC>